Published in J Clin Invest on October 01, 1999
Adiposity and Airway Inflammation in HIV-Associated Airway Disease (SHOP) | NCT02975258
Cellular and molecular mechanisms of fibrosis. J Pathol (2008) 14.01
Interleukin-13 induces tissue fibrosis by selectively stimulating and activating transforming growth factor beta(1). J Exp Med (2001) 4.71
Dissection of experimental asthma with DNA microarray analysis identifies arginase in asthma pathogenesis. J Clin Invest (2003) 4.08
Vascular endothelial growth factor (VEGF) induces remodeling and enhances TH2-mediated sensitization and inflammation in the lung. Nat Med (2004) 3.64
Role of chitin and chitinase/chitinase-like proteins in inflammation, tissue remodeling, and injury. Annu Rev Physiol (2011) 3.25
Inhibition of airway remodeling in IL-5-deficient mice. J Clin Invest (2004) 3.06
MicroRNA-21 is up-regulated in allergic airway inflammation and regulates IL-12p35 expression. J Immunol (2009) 2.89
Early growth response gene 1-mediated apoptosis is essential for transforming growth factor beta1-induced pulmonary fibrosis. J Exp Med (2004) 2.84
Overlapping and enzyme-specific contributions of matrix metalloproteinases-9 and -12 in IL-13-induced inflammation and remodeling. J Clin Invest (2002) 2.52
New insights into the role of cytokines in asthma. J Clin Pathol (2001) 2.09
Prolonged allergen challenge in mice leads to persistent airway remodelling. Clin Exp Allergy (2004) 2.00
Effective mucus clearance is essential for respiratory health. Am J Respir Cell Mol Biol (2006) 1.98
Adenosine mediates IL-13-induced inflammation and remodeling in the lung and interacts in an IL-13-adenosine amplification pathway. J Clin Invest (2003) 1.90
Ultrastructural examination of bronchial biopsy specimens from children with moderate asthma. Thorax (2001) 1.85
Periostin facilitates eosinophil tissue infiltration in allergic lung and esophageal responses. Mucosal Immunol (2008) 1.79
TSLP conditions the lung immune environment for the generation of pathogenic innate and antigen-specific adaptive immune responses. J Immunol (2009) 1.70
Infectious disease, the innate immune response, and fibrosis. J Clin Invest (2007) 1.68
Semaphorin 7A plays a critical role in TGF-beta1-induced pulmonary fibrosis. J Exp Med (2007) 1.67
Adiponectin deficiency increases allergic airway inflammation and pulmonary vascular remodeling. Am J Respir Cell Mol Biol (2009) 1.65
Transforming growth factor-beta1 suppresses airway hyperresponsiveness in allergic airway disease. Am J Respir Crit Care Med (2007) 1.63
Jun N-terminal kinase 1 regulates epithelial-to-mesenchymal transition induced by TGF-beta1. J Cell Sci (2008) 1.60
Is chronic asthma associated with shorter leukocyte telomere length at midlife? Am J Respir Crit Care Med (2014) 1.55
Altered lymphocyte trafficking and diminished airway reactivity in transgenic mice expressing human MMP-9 in a mouse model of asthma. Am J Physiol Lung Cell Mol Physiol (2009) 1.48
Persistent effects induced by IL-13 in the lung. Am J Respir Cell Mol Biol (2006) 1.47
Complex interactions in complex traits: obesity and asthma. Thorax (2001) 1.42
The cell biology of asthma. J Cell Biol (2014) 1.40
Epithelial cell proliferation contributes to airway remodeling in severe asthma. Am J Respir Crit Care Med (2007) 1.36
Correlation between the bronchial subepithelial layer and whole airway wall thickness in patients with asthma. Thorax (2002) 1.32
Transgenic modeling of transforming growth factor-beta(1): role of apoptosis in fibrosis and alveolar remodeling. Proc Am Thorac Soc (2006) 1.31
Eosinophils in the pathogenesis of allergic airways disease. Cell Mol Life Sci (2007) 1.26
c-Jun N-terminal kinase 1 is required for the development of pulmonary fibrosis. Am J Respir Cell Mol Biol (2008) 1.26
Mouse and human lung fibroblasts regulate dendritic cell trafficking, airway inflammation, and fibrosis through integrin αvβ8-mediated activation of TGF-β. J Clin Invest (2011) 1.25
IL-13 induces skin fibrosis in atopic dermatitis by thymic stromal lymphopoietin. J Immunol (2011) 1.25
Cultured lung fibroblasts from ovalbumin-challenged "asthmatic" mice differ functionally from normal. Am J Respir Cell Mol Biol (2007) 1.22
Mechanisms of remodeling in asthmatic airways. J Allergy (Cairo) (2012) 1.20
Role of hyaluronan and hyaluronan-binding proteins in human asthma. J Allergy Clin Immunol (2011) 1.19
Alterations in adenosine metabolism and signaling in patients with chronic obstructive pulmonary disease and idiopathic pulmonary fibrosis. PLoS One (2010) 1.16
Airway remodelling in asthma: from benchside to clinical practice. Can Respir J (2010) 1.11
Distinctive characteristics of bronchial reticular basement membrane and vessel remodelling in chronic obstructive pulmonary disease (COPD) and in asthma: they are not the same disease. Histopathology (2012) 1.09
Pathogenicity of a disease-associated human IL-4 receptor allele in experimental asthma. J Exp Med (2009) 1.07
Prostaglandin E2 activates EP2 receptors to inhibit human lung mast cell degranulation. Br J Pharmacol (2006) 1.07
IL-13 regulates cilia loss and foxj1 expression in human airway epithelium. Am J Respir Cell Mol Biol (2007) 1.04
FIZZ2/RELM-β induction and role in pulmonary fibrosis. J Immunol (2011) 1.01
Asthma morbidity and treatment in children with sickle cell disease. Expert Rev Respir Med (2011) 1.00
Pirfenidone modulates airway responsiveness, inflammation, and remodeling after repeated challenge. Am J Respir Cell Mol Biol (2006) 0.99
Induction of MCP-1 expression in airway epithelial cells: role of CCR2 receptor in airway epithelial injury. J Clin Immunol (2002) 0.99
Acidic mammalian chitinase regulates epithelial cell apoptosis via a chitinolytic-independent mechanism. J Immunol (2009) 0.99
Treatment of asthma and food allergy with herbal interventions from traditional chinese medicine. Mt Sinai J Med (2011) 0.98
Inhibition of MMP-9 expression by PPARgamma activators in human bronchial epithelial cells. Thorax (2003) 0.97
Lymphatics in lung disease. Ann N Y Acad Sci (2008) 0.97
ISO-1, a macrophage migration inhibitory factor antagonist, inhibits airway remodeling in a murine model of chronic asthma. Mol Med (2010) 0.97
Association of inducible nitric oxide synthase with asthma severity, total serum immunoglobulin E and blood eosinophil levels. Thorax (2007) 0.96
IL-4 and IL-13 signaling in allergic airway disease. Cytokine (2015) 0.96
The protease allergen Pen c 13 induces allergic airway inflammation and changes in epithelial barrier integrity and function in a murine model. J Biol Chem (2011) 0.95
Asthma and pulmonary arterial hypertension: do they share a key mechanism of pathogenesis? Eur Respir J (2010) 0.95
Increased transcription of cytokine genes in human lung epithelial cells through activation of a TRPM8 variant by cold temperatures. Am J Physiol Lung Cell Mol Physiol (2008) 0.95
Anti-Fas mAb-induced apoptosis and cytolysis of airway tissue eosinophils aggravates rather than resolves established inflammation. Respir Res (2005) 0.95
Mechanism of eosinophilic esophagitis. Immunol Allergy Clin North Am (2009) 0.93
HMGB1 contributes to allergen-induced airway remodeling in a murine model of chronic asthma by modulating airway inflammation and activating lung fibroblasts. Cell Mol Immunol (2014) 0.92
alpha3alpha5beta2-Nicotinic acetylcholine receptor contributes to the wound repair of the respiratory epithelium by modulating intracellular calcium in migrating cells. Am J Pathol (2006) 0.92
Absence of alpha 4 but not beta 2 integrins restrains development of chronic allergic asthma using mouse genetic models. Exp Hematol (2009) 0.92
IL-13 induces a bronchial epithelial phenotype that is profibrotic. Respir Res (2008) 0.92
TRP channels in airway smooth muscle as therapeutic targets. Naunyn Schmiedebergs Arch Pharmacol (2005) 0.92
Assessment of airway hyperreactivity: comparison of forced spirometry and body plethysmography for methacholine challenge tests. Eur J Med Res (2009) 0.91
Overlap Between Asthma and COPD: Where the Two Diseases Converge. Allergy Asthma Immunol Res (2010) 0.90
Autocrine regulation of asthmatic airway inflammation: role of airway smooth muscle. Respir Res (2001) 0.90
Genetically manipulated mouse models of lung disease: potential and pitfalls. Am J Physiol Lung Cell Mol Physiol (2011) 0.90
Identification of genes expressed by human airway eosinophils after an in vivo allergen challenge. PLoS One (2013) 0.90
Lung remodeling in a mouse model of asthma involves a balance between TGF-β1 and BMP-7. PLoS One (2014) 0.89
Nickel alterations of TLR2-dependent chemokine profiles in lung fibroblasts are mediated by COX-2. Am J Respir Cell Mol Biol (2007) 0.89
Nitric oxide metabolism in asthma pathophysiology. Biochim Biophys Acta (2011) 0.89
Tissue inhibitor of metalloproteinase-1 modulates allergic lung inflammation in murine asthma. Clin Immunol (2008) 0.88
Multi-scale computational models of the airways to unravel the pathophysiological mechanisms in asthma and chronic obstructive pulmonary disease (AirPROM). Interface Focus (2013) 0.88
Cigarette smoke alters tissue inhibitor of metalloproteinase 1 and matrix metalloproteinase 9 levels in the basolateral secretions of human asthmatic bronchial epithelium in vitro. J Investig Med (2010) 0.88
Superoxide dismutase 3 controls adaptive immune responses and contributes to the inhibition of ovalbumin-induced allergic airway inflammation in mice. Antioxid Redox Signal (2012) 0.87
MAPK regulation of IL-4/IL-13 receptors contributes to the synergistic increase in CCL11/eotaxin-1 in response to TGF-β1 and IL-13 in human airway fibroblasts. J Immunol (2012) 0.87
In vivo disruption of TGF-beta signaling by Smad7 in airway epithelium alleviates allergic asthma but aggravates lung carcinogenesis in mouse. PLoS One (2010) 0.87
Identification of antigenic epitopes on human allergens: studies with HLA transgenic mice. Environ Health Perspect (2003) 0.86
STAT6 controls the number of regulatory T cells in vivo, thereby regulating allergic lung inflammation. J Immunol (2013) 0.85
Role of ADAM33 gene and associated single nucleotide polymorphisms in asthma. Allergy Rhinol (Providence) (2011) 0.85
Regulation of type 1 diabetes, tuberculosis, and asthma by parasites. J Mol Med (Berl) (2009) 0.85
Do two mutually exclusive gene modules define the phenotypic diversity of mammalian smooth muscle? Mol Genet Genomics (2008) 0.85
Reversal of established CD4+ type 2 T helper-mediated allergic airway inflammation and eosinophilia by therapeutic treatment with DNA vaccines limits progression towards chronic inflammation and remodelling. Immunology (2004) 0.84
Stem cells in airway smooth muscle: state of the art. Proc Am Thorac Soc (2008) 0.83
Prolonged ozone exposure in an allergic airway disease model: adaptation of airway responsiveness and airway remodeling. Respir Res (2006) 0.83
Central role of IL-17/Th17 immune responses and the gut microbiota in the pathogenesis of intestinal fibrosis. Curr Opin Gastroenterol (2014) 0.83
Application of vitamin E to antagonize SWCNTs-induced exacerbation of allergic asthma. Sci Rep (2014) 0.82
Evaluation of the Effects of Caffeic Acid Phenethyl Ester on Prostaglandin E2 and Two Key Cytokines Involved in Bleomycin-induced Pulmonary Fibrosis. Iran J Basic Med Sci (2013) 0.81
Chemokines and their role in airway hyper-reactivity. Respir Res (2000) 0.81
Deficiency in the serum-derived hyaluronan-associated protein-hyaluronan complex enhances airway hyperresponsiveness in a murine model of asthma. Int Arch Allergy Immunol (2010) 0.81
Ultrastructural changes of airway in murine models of allergy and diet-induced metabolic syndrome. ISRN Allergy (2013) 0.81
Mechanical compression attenuates normal human bronchial epithelial wound healing. Respir Res (2009) 0.81
Depletion of CD8+ T cells enhances airway remodelling in a rodent model of asthma. Immunology (2008) 0.80
Cross-talk between human mast cells and bronchial epithelial cells in plasminogen activator inhibitor-1 production via transforming growth factor-β1. Am J Respir Cell Mol Biol (2015) 0.79
Characterization of a novel model incorporating airway epithelial damage and related fibrosis to the pathogenesis of asthma. Lab Invest (2014) 0.79
Host cell cytokines induced by Chlamydia pneumoniae decrease the expression of interstitial collagens and fibronectin in fibroblasts. Infect Immun (2008) 0.79
CD8+ T cells and immunoregulatory networks in asthma. Springer Semin Immunopathol (2003) 0.79
ETB receptor polymorphism is associated with airway obstruction. BMC Pulm Med (2007) 0.78
Investigating in vivo airway wall mechanics during tidal breathing with optical coherence tomography. J Biomed Opt (2011) 0.78
An essential regulatory role of downstream of kinase-1 in the ovalbumin-induced murine model of asthma. PLoS One (2012) 0.78
Interleukin-13: central mediator of allergic asthma. Science (1998) 14.05
Predominant TH2-like bronchoalveolar T-lymphocyte population in atopic asthma. N Engl J Med (1992) 11.90
Pulmonary expression of interleukin-13 causes inflammation, mucus hypersecretion, subepithelial fibrosis, physiologic abnormalities, and eotaxin production. J Clin Invest (1999) 8.38
A 15-year follow-up study of ventilatory function in adults with asthma. N Engl J Med (1998) 4.52
Expression of mRNA for interleukin-5 in mucosal bronchial biopsies from asthma. J Clin Invest (1991) 3.88
Subepithelial fibrosis in the bronchi of asthmatics. Lancet (1989) 3.70
Eosinophil-associated TGF-beta1 mRNA expression and airways fibrosis in bronchial asthma. Am J Respir Cell Mol Biol (1997) 2.84
Interleukin-5 expression in the lung epithelium of transgenic mice leads to pulmonary changes pathognomonic of asthma. J Exp Med (1997) 2.77
Phenotypic and physiologic characterization of transgenic mice expressing interleukin 4 in the lung: lymphocytic and eosinophilic inflammation without airway hyperreactivity. Proc Natl Acad Sci U S A (1996) 2.70
Cellular hypertrophy and hyperplasia of airway smooth muscles underlying bronchial asthma. A 3-D morphometric study. Am Rev Respir Dis (1993) 2.69
Expression of interleukin 9 in the lungs of transgenic mice causes airway inflammation, mast cell hyperplasia, and bronchial hyperresponsiveness. J Exp Med (1998) 2.55
Small airways dimensions in asthma and in chronic obstructive pulmonary disease. Am Rev Respir Dis (1993) 2.51
Transforming growth factor-beta expression in mucosal biopsies in asthma and chronic bronchitis. Am J Respir Crit Care Med (1997) 2.47
Sputum metalloproteinase-9/tissue inhibitor of metalloproteinase-1 ratio correlates with airflow obstruction in asthma and chronic bronchitis. Am J Respir Crit Care Med (1998) 2.36
Rate of decline of lung function in subjects with asthma. Eur J Respir Dis (1987) 2.27
Myofibroblasts and subepithelial fibrosis in bronchial asthma. Am J Respir Cell Mol Biol (1990) 2.14
Marked goblet cell hyperplasia with mucus accumulation in the airways of patients who died of severe acute asthma attack. Chest (1992) 2.13
Effects of treatment on airway inflammation and thickening of basement membrane reticular collagen in asthma. A quantitative light and electron microscopic study. Am Rev Respir Dis (1992) 2.02
Airway epithelial cell expression of interleukin-6 in transgenic mice. Uncoupling of airway inflammation and bronchial hyperreactivity. J Clin Invest (1994) 1.96
Interleukin 9: a candidate gene for asthma. Proc Natl Acad Sci U S A (1997) 1.84
Lung inflammation and epithelial changes in a murine model of atopic asthma. Am J Respir Cell Mol Biol (1996) 1.75
Airways remodeling is a distinctive feature of asthma and is related to severity of disease. Chest (1997) 1.71
Airway inflammation in mild intermittent and in persistent asthma. Am J Respir Crit Care Med (1998) 1.69
Transforming growth factor beta 1 (TGF beta 1) gene expression by eosinophils in asthmatic airway inflammation. Am J Respir Cell Mol Biol (1996) 1.66
Bronchial subepithelial fibrosis and expression of matrix metalloproteinase-9 in asthmatic airway inflammation. J Allergy Clin Immunol (1998) 1.62
Targeted expression of IL-11 in the murine airway causes lymphocytic inflammation, bronchial remodeling, and airways obstruction. J Clin Invest (1996) 1.58
Myofibroblast involvement in the allergen-induced late response in mild atopic asthma. Am J Respir Cell Mol Biol (1997) 1.48
Expression of growth factors and remodelling of the airway wall in bronchial asthma. Thorax (1998) 1.47
Collagen deposition in large airways may not differentiate severe asthma from milder forms of the disease. Am J Respir Crit Care Med (1998) 1.47
Airway responsiveness and bronchial-wall thickness in asthma with or without fixed airflow obstruction. Am J Respir Crit Care Med (1995) 1.37
Interleukin-11: stimulation in vivo and in vitro by respiratory viruses and induction of airways hyperresponsiveness. J Clin Invest (1996) 1.27
Pathophysiology of asthma. Br J Clin Pharmacol (1996) 1.25
Interleukin-4 alters epithelial cell differentiation and surfactant homeostasis in the postnatal mouse lung. Am J Respir Cell Mol Biol (1997) 1.24
Parainfluenza virus-induced persistence of airway inflammation, fibrosis, and dysfunction associated with TGF-beta 1 expression in brown Norway rats. Am J Respir Crit Care Med (1996) 1.15
Airway goblet cell mucin: its structure and regulation of secretion. Eur Respir J (1997) 1.10
Airway smooth muscle in asthma: flirting with disaster. Eur Respir J (1998) 1.05
New insights into airway inflammation by endobronchial biopsy. Am Rev Respir Dis (1992) 1.02
The functional consequences of airway remodeling in asthma. Monaldi Arch Chest Dis (1997) 1.01
Airway wall remodeling after cessation of exposure to isocyanates in sensitized asthmatic subjects. Am J Respir Crit Care Med (1995) 1.00
Increased expression of tissue inhibitor of metalloproteinase-1 and loss of correlation with matrix metalloproteinase-9 by macrophages in asthma. Lab Invest (1999) 1.00
Interleukin-11. Int J Biochem Cell Biol (1998) 0.91
Mutation detection and single-molecule counting using isothermal rolling-circle amplification. Nat Genet (1998) 9.84
Impaired recruitment of bone-marrow-derived endothelial and hematopoietic precursor cells blocks tumor angiogenesis and growth. Nat Med (2001) 9.53
Expression of VEGFR-2 and AC133 by circulating human CD34(+) cells identifies a population of functional endothelial precursors. Blood (2000) 9.24
Pulmonary expression of interleukin-13 causes inflammation, mucus hypersecretion, subepithelial fibrosis, physiologic abnormalities, and eotaxin production. J Clin Invest (1999) 8.38
Interleukin-13 induces tissue fibrosis by selectively stimulating and activating transforming growth factor beta(1). J Exp Med (2001) 4.71
Sonic hedgehog--regulated oligodendrocyte lineage genes encoding bHLH proteins in the mammalian central nervous system. Neuron (2000) 4.17
Inducible targeting of IL-13 to the adult lung causes matrix metalloproteinase- and cathepsin-dependent emphysema. J Clin Invest (2000) 4.16
Intracellular transport of newly synthesized varicella-zoster virus: final envelopment in the trans-Golgi network. J Virol (1994) 3.72
Induction of airway mucus production By T helper 2 (Th2) cells: a critical role for interleukin 4 in cell recruitment but not mucus production. J Exp Med (1997) 3.33
Vascular endothelial growth factor and angiopoietin-1 stimulate postnatal hematopoiesis by recruitment of vasculogenic and hematopoietic stem cells. J Exp Med (2001) 3.25
Immunoassays with rolling circle DNA amplification: a versatile platform for ultrasensitive antigen detection. Proc Natl Acad Sci U S A (2000) 2.75
Monoclonal antibodies targeting the VEGF receptor-2 (Flk1/KDR) as an anti-angiogenic therapeutic strategy. Cancer Metastasis Rev (1998) 2.55
Interferon gamma induction of pulmonary emphysema in the adult murine lung. J Exp Med (2000) 2.36
Discovery of nonsteroidal androgens. Biochem Biophys Res Commun (1998) 2.21
Autocrine stimulation of VEGFR-2 activates human leukemic cell growth and migration. J Clin Invest (2000) 2.08
Non-invasive prenatal testing for trisomies 21, 18 and 13: clinical experience from 146,958 pregnancies. Ultrasound Obstet Gynecol (2015) 2.07
In vitro and in vivo studies of methylseleninic acid: evidence that a monomethylated selenium metabolite is critical for cancer chemoprevention. Cancer Res (2000) 2.06
Clinicians are from Mars and pathologists are from Venus. Arch Pathol Lab Med (2000) 2.05
Interleukin-6-induced protection in hyperoxic acute lung injury. Am J Respir Cell Mol Biol (2000) 2.03
An efficient route to human bispecific IgG. Nat Biotechnol (1998) 1.93
Inhibition of both paracrine and autocrine VEGF/ VEGFR-2 signaling pathways is essential to induce long-term remission of xenotransplanted human leukemias. Proc Natl Acad Sci U S A (2001) 1.90
T helper 1 cells and interferon gamma regulate allergic airway inflammation and mucus production. J Exp Med (1999) 1.85
Role for macrophage migration inhibitory factor in asthma. Proc Natl Acad Sci U S A (2005) 1.79
Copper-specific transcriptional repression of yeast genes encoding critical components in the copper transport pathway. J Biol Chem (1997) 1.76
Th2-induced airway mucus production is dependent on IL-4Ralpha, but not on eosinophils. J Immunol (1999) 1.70
IL-13 stimulates vascular endothelial cell growth factor and protects against hyperoxic acute lung injury. J Clin Invest (2000) 1.66
Negative regulation of lncRNA GAS5 by miR-21. Cell Death Differ (2013) 1.60
Targeted expression of IL-11 in the murine airway causes lymphocytic inflammation, bronchial remodeling, and airways obstruction. J Clin Invest (1996) 1.58
Essential role played by the C-terminal domain of glycoprotein I in envelopment of varicella-zoster virus in the trans-Golgi network: interactions of glycoproteins with tegument. J Virol (2001) 1.55
Targeted lung expression of interleukin-11 enhances murine tolerance of 100% oxygen and diminishes hyperoxia-induced DNA fragmentation. J Clin Invest (1998) 1.54
Airway hyperresponsiveness and airway obstruction in transgenic mice. Morphologic correlates in mice overexpressing interleukin (IL)-11 and IL-6 in the lung. Am J Respir Cell Mol Biol (2000) 1.51
Respiratory rate and signs in roentgenographically confirmed pneumonia among children in China. Pediatr Infect Dis J (1995) 1.50
Use of the tetracycline-controlled transcriptional silencer (tTS) to eliminate transgene leak in inducible overexpression transgenic mice. J Biol Chem (2001) 1.48
Randomized, double-blind, placebo-controlled trial of oral enalapril in patients with neurally mediated syncope. Am Heart J (1998) 1.43
Clinical, biochemical, and neuropathologic findings following transplantation of adrenal medulla to the caudate nucleus for treatment of Parkinson's disease. Neurology (1989) 1.43
Observation of a centrality-dependent dijet asymmetry in lead-lead collisions at sqrt[S(NN)] =2.76 TeV with the ATLAS detector at the LHC. Phys Rev Lett (2010) 1.41
Full velocity difference model for a car-following theory. Phys Rev E Stat Nonlin Soft Matter Phys (2001) 1.38
White adipose tissue contributes to UCP1-independent thermogenesis. Am J Physiol Endocrinol Metab (2003) 1.35
Search for new particles in two-jet final states in 7 TeV proton-proton collisions with the ATLAS detector at the LHC. Phys Rev Lett (2010) 1.32
Morphological variety of the soft palate in normal individuals: a digital cephalometric study. Dentomaxillofac Radiol (2008) 1.28
Interleukin-11: stimulation in vivo and in vitro by respiratory viruses and induction of airways hyperresponsiveness. J Clin Invest (1996) 1.27
Three sequence-specific DNA-protein complexes are formed with the same promoter element essential for expression of the rat somatostatin gene. Mol Cell Biol (1988) 1.24
Kinetics of serological responses in influenza A(H7N9)-infected patients correlate with clinical outcome in China, 2013. Euro Surveill (2013) 1.24
Identification of the residues in the extracellular region of KDR important for interaction with vascular endothelial growth factor and neutralizing anti-KDR antibodies. J Biol Chem (2000) 1.21
Structural basis of activation and GTP hydrolysis in Rab proteins. Structure (1999) 1.19
Blood pressure-lowering effects of GLP-1 receptor agonists exenatide and liraglutide: a meta-analysis of clinical trials. Diabetes Obes Metab (2013) 1.18
Identification and characterization of a 19q12 amplicon in esophageal adenocarcinomas reveals cyclin E as the best candidate gene for this amplicon. Cancer Res (2000) 1.17
Respiratory syncytial virus stimulation of vascular endothelial cell growth Factor/Vascular permeability factor. Am J Respir Cell Mol Biol (2000) 1.17
Aryloxypropanolamine and catecholamine ligand interactions with the beta(1)-adrenergic receptor: evidence for interaction with distinct conformations of beta(1)-adrenergic receptors. J Pharmacol Exp Ther (2000) 1.14
Sequence of genome segments 1, 2, and 3 of the grass carp reovirus (Genus Aquareovirus, family Reoviridae). Biochem Biophys Res Commun (2000) 1.14
Homeobox gene IRX1 is a tumor suppressor gene in gastric carcinoma. Oncogene (2010) 1.14
Vascular endothelial growth factor (VEGF) receptor-2 antagonists inhibit VEGF- and basic fibroblast growth factor-induced angiogenesis in vivo and in vitro. J Pharmacol Exp Ther (2001) 1.13
Saccharomyces cerevisiae mutants altered in vacuole function are defective in copper detoxification and iron-responsive gene transcription. Yeast (1997) 1.13
Soluble recombinant endostatin purified from Escherichia coli: antiangiogenic activity and antitumor effect. Cancer Res (2001) 1.08
Neurotensin receptor-1 mRNA analysis in normal pancreas and pancreatic disease. Clin Cancer Res (2000) 1.08
A vacuum pressure sensor based on ZnO nanobelt film. Nanotechnology (2011) 1.08
Comparative analysis of galectins in primary tumors and tumor metastasis in human pancreatic cancer. J Histochem Cytochem (2001) 1.07
Prognostic significance of monitoring leukemia-associated immunophenotypes by eight-color flow cytometry in adult B-acute lymphoblastic leukemia. Blood Cancer J (2013) 1.06
Endogenous and exogenous IL-6 inhibit aeroallergen-induced Th2 inflammation. J Immunol (2000) 1.05
Interleukin-37 ameliorates myocardial ischaemia/reperfusion injury in mice. Clin Exp Immunol (2014) 1.04
IL-11 selectively inhibits aeroallergen-induced pulmonary eosinophilia and Th2 cytokine production. J Immunol (2000) 1.03
Sequence and insertion sites of murine melanoma-associated retrovirus. J Virol (1999) 1.03
Platelet-derived growth factor (PDGF) gene delivery for application in periodontal tissue engineering. J Periodontol (2001) 1.02
Galectin-1 and galectin-3 in chronic pancreatitis. Lab Invest (2000) 1.02
Energy availability and mammary carcinogenesis: effects of calorie restriction and exercise. Carcinogenesis (1997) 1.01
Ocular effects of exposure to triethylamine in the sand core cold box of a foundry. Occup Environ Med (1995) 1.01
Morphological and biochemical status of the mammary gland as influenced by conjugated linoleic acid: implication for a reduction in mammary cancer risk. Cancer Res (1997) 1.00
Immunofluorescence signal amplification by the enzyme-catalyzed deposition of a fluorescent reporter substrate (CARD). Cytometry (1996) 1.00
Activation of FGFR1beta signaling pathway promotes survival, migration and resistance to chemotherapy in acute myeloid leukemia cells. Leukemia (2006) 0.98
Airway inflammation and remodeling in asthma. Lessons from interleukin 11 and interleukin 13 transgenic mice. Am J Respir Crit Care Med (2001) 0.98
Hyperbaric oxygen preconditioning induces neuroprotection against ischemia in transient not permanent middle cerebral artery occlusion rat model. Chin Med J (Engl) (2000) 0.97
IL-11 expression is increased in severe asthma: association with epithelial cells and eosinophils. J Allergy Clin Immunol (2000) 0.97
NK-1 receptor gene expression is related to pain in chronic pancreatitis. Pain (2001) 0.97
Role of tissue factor in metastasis: functions of the cytoplasmic and extracellular domains of the molecule. Thromb Haemost (1999) 0.96
Growth factor receptors are differentially expressed in cancers of the papilla of vater and pancreas. Ann Surg (1999) 0.96
Eosinophilic pneumonia as a presentation of occult chronic granulomatous disease. Eur Respir J (1997) 0.96
Airway isocyanate-adducts in asthma induced by exposure to hexamethylene diisocyanate. Scand J Work Environ Health (1997) 0.95
Intracellular transport of varicella-zoster glycoproteins. J Infect Dis (1998) 0.94
Apoptosis induction by a novel anti-prostate cancer compound, BMD188 (a fatty acid-containing hydroxamic acid), requires the mitochondrial respiratory chain. Cancer Res (1999) 0.94
Effects of hydrogen peroxide on human dentin structure. J Dent Res (2007) 0.94
Autoimmune dacryoadenitis and keratoconjunctivitis induced in rabbits by subcutaneous injection of autologous lymphocytes activated ex vivo against lacrimal antigens. J Autoimmun (2008) 0.93
Phosphorylation and Cu+ coordination-dependent DNA binding of the transcription factor Mac1p in the regulation of copper transport. J Biol Chem (2000) 0.93
Rhinovirus regulation of IL-1 receptor antagonist in vivo and in vitro: a potential mechanism of symptom resolution. J Immunol (1999) 0.93
Use of skin-cancer prevention strategies among farmers and their spouses. Am J Prev Med (1996) 0.92
Hepatitis C virus NS3-4A serine protease inhibitors: SAR of P'2 moiety with improved potency. Bioorg Med Chem Lett (2005) 0.92
Mechanical properties of the periosteum in the pig, Sus scrofa. Arch Oral Biol (2002) 0.92
Evaluations of cellulose accessibilities of lignocelluloses by solute exclusion and protein adsorption techniques. Biotechnol Bioeng (2011) 0.91
The NMR chemical shift pH measurement revisited: analysis of error and modeling of a pH dependent reference. Magn Reson Med (1996) 0.91
Over-representation of the disease associated (CAG) and (CGG) repeats in the human genome. Nucleic Acids Res (1994) 0.91
The influence of acupuncture on the impedance measured by four electrodes on meridians. Acupunct Electrother Res (1999) 0.91
Studies designed to increase the stability and antiviral activity (HCMV) of the active benzimidazole nucleoside, TCRB. Nucleosides Nucleotides (1999) 0.91
Detection of fetal sex chromosome aneuploidy by massively parallel sequencing of maternal plasma DNA: initial experience in a Chinese hospital. Ultrasound Obstet Gynecol (2014) 0.91